SCHEMBL20114570

SCHEMBL20114570

N#Cc1ccc(-c2ccc3c4ccccc4n(-c4cc(C#N)ccc4-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c3c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 11/20 0.39
ABCB1 P08183 5/20 0.39
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
CYP1A2 P05177 4/20 0.38
ALDH1A1 P00352 3/20 0.38
CYP3A4 P08684 3/20 0.38
LMNA P02545 3/20 0.38
CYP2C19 P33261 2/20 0.38
CLK4 Q9HAZ1 2/20 0.38
TSHR P16473 2/20 0.38
HSD17B10 Q99714 2/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2C9 P11712 1/20 0.38
ATM Q13315 1/20 0.37
ABCC1 P33527 2/20 0.36
ALDH1A3 P47895 1/20 0.36
MAPK1 P28482 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRG2 P18507 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27016009 0.96 ABCG2 (0.41) ABCG2ABCB1MEN1KMT2ACYP1A2
SCHEMBL26496834 0.94 CYP1A2 (0.41) ABCG2ABCB1MEN1KMT2ACYP1A2
SCHEMBL20114560 0.94 MEN1 (0.38) ABCG2ABCB1MEN1KMT2ACYP1A2
SCHEMBL20114571 0.94 PTGER4 (0.40) ABCG2ABCB1MEN1KMT2ACYP1A2
SCHEMBL27015943 0.93 ABCG2 (0.39) ABCG2ABCB1MEN1KMT2ACYP1A2
SCHEMBL22268544 0.93 ABCG2 (0.40) ABCG2ABCB1MEN1KMT2ALMNA
SCHEMBL27016015 0.93 PTGER4 (0.39) ABCG2ABCB1MEN1KMT2ACYP1A2
SCHEMBL21742003 0.92 PTGER4 (0.39) ABCG2ABCB1MEN1KMT2ACYP1A2
SCHEMBL20114541 0.92 PTGER4 (0.39) ABCG2ABCB1MEN1KMT2ACYP1A2
SCHEMBL21742002 0.92 CYP1A2 (0.43) ABCG2ABCB1MEN1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-09-24 US disclosed
EP-3315581-B1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-01-02 EP disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed
EP-3315581-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, EPCAM, F12 ABCG2 2585/4885ABCB1 1061/4885MEN1 2430/4885
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, EPCAM, F12 ABCG2 2585/4885ABCB1 1061/4885MEN1 2430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.